Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2012
02/28/2012US8124840 Regulating metabolism by modifying the level of trehalose-6-phosphate
02/28/2012US8124839 Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations
02/28/2012US8124838 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
02/28/2012US8124837 Engineering resistance to Pierce's disease by expression of a Xyella fastidiosa HecA-like hemagglutinin protein
02/28/2012US8124836 Zea mays ABA signaling genes and methods of use
02/28/2012US8124834 Use of active cytokinin synthase gene
02/28/2012US8124832 Method for producing cloned dog
02/28/2012US8124830 Transgenic non-human animals expressing a truncated activin type II receptor
02/28/2012US8124829 Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof
02/28/2012US8124755 hTERT gene expression regulatory gene
02/28/2012US8124754 Double-stranded nucleic acid molecule cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer, and bladder cancer
02/28/2012US8124753 Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene
02/28/2012US8124750 Recombinant protective protein from Streptococcus pneumoniae
02/28/2012US8124748 Cell surface glycoprotein
02/28/2012US8124745 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
02/28/2012US8124742 for isolation of DNA encoding anti-Rh(D) antibodies; isolation of DNA encoding antibodies directed against any red blood cells antigen or other cell antigen; for typing platelets by generating phage antibodies specific for a number of clinically important platelet antigens
02/28/2012US8124739 Antibody to human Zcyto10 polypeptide
02/28/2012US8124733 Tumor suppressor gene
02/28/2012US8124729 Splice variants of human G-protein coupled receptor HGPRBMY29 (HGPRMBY29SV2)
02/28/2012US8124728 CA125 gene and its use for diagnostic and therapeutic interventions
02/28/2012US8124723 Circovirus sequences associated with piglet weight loss disease (PWD)
02/28/2012US8124592 Development of a preventive vaccine for filovirus infection in primates
02/28/2012US8124591 DNA vaccine comprising IL-6-encoding DNA construct and applications thereof
02/28/2012US8124590 Biodegradable immunomodulatory formulations and methods for use thereof
02/28/2012US8124588 Chimeric plasminogen activators and their pharmaceutical use
02/28/2012US8124586 Prevention and reduction of blood loss
02/28/2012US8124424 Single molecule-format bioluminescent probe
02/28/2012US8124407 Circular nucleic acid vectors, and methods for making and using the same
02/28/2012US8124406 Method for modifying chromosomes
02/28/2012US8124405 Fusion proteins
02/28/2012US8124404 Stable integrands
02/28/2012US8124399 Enhanced protein expression in Bacillus
02/28/2012US8124395 Alpha-amylase variants
02/28/2012US8124391 Heat resistant proteolytic enzymes for use as diagnostic and DNA amplification tool
02/28/2012US8124388 Production of 3-hydroxypropionic acid using beta-alanine/pyruvate aminotransferase
02/28/2012US8124385 Enhanced production of lipids containing polyenoic fatty acid by very high density cultures of eukaryotic microbes in fermentors
02/28/2012US8124384 Enhanced production of lipids containing polyenoic fatty acid by very high density cultures of eukaryotic microbes in fermentors
02/28/2012US8124381 Process and materials for production of glucosamine and N-acetylglucosamine
02/28/2012US8124379 Signal peptide for producing a polypeptide
02/28/2012US8124378 Murine zcytor17 ligand polynucleotides
02/28/2012US8124375 Geraniol synthase, methods of production and uses thereof
02/28/2012US8124374 Method of producing recombinant protein
02/28/2012US8124373 Isomaltulose synthases, polynucleotides encoding them and uses therefor
02/28/2012US8124372 Selective enzymatic amidation of C-terminal esters or acids of peptides
02/28/2012US8124361 Methods of screening for sweet taste modulators
02/28/2012US8124357 Cell comprising exogenous clostridial toxin receptor for use as quality control agents in pharmaceutical and food processing
02/28/2012US8124352 Methods and compositions for targeting HEPSIN
02/28/2012US8124342 Methods for nucleic acid manipulation
02/28/2012US8124341 Genes and polypeptides relating to hepatocellular or colorectal carcinoma
02/28/2012US8124330 Screening methods for cognitive enhancers
02/28/2012US8124105 Compositions, methods and kits relating to poxvirus subunit vaccines
02/28/2012US8124104 Norovirus and sapovirus antigens
02/28/2012US8124100 Inactivated nodavirus vaccine
02/28/2012US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders
02/28/2012US8124078 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies
02/28/2012US8124074 Fusion proteins
02/28/2012US8124068 Recombinant intracellular pathogen immunogenic compositions and methods of use
02/28/2012US8124067 Method for immunotherapy of tumors
02/28/2012US8124066 Methods of using interleukin-2 mutants with reduced toxicity
02/28/2012US8124056 High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds
02/28/2012US8124052 for drug screening antitumor angents; genetic engineering; microarrays; kits
02/28/2012CA2633281C Novel mutations relating to x-linked charcot-marie-tooth disease
02/28/2012CA2592071C Transcription factor gene osnacx from rice and use thereof for improving plant tolerance to drought and salt
02/28/2012CA2485506C A method for in vitro molecular evolution of protein function
02/28/2012CA2480121C Methods for increasing polypeptide production
02/28/2012CA2417860C Novel variant egiii-like cellulase compositions
02/28/2012CA2402240C A method for in vitro molecular evolution of antibody function
02/28/2012CA2397067C Cell isolation method
02/28/2012CA2392202C Constructs for delivery of therapeutic agents to neuronal cells
02/28/2012CA2339901C Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences
02/28/2012CA2219361C Human antibodies derived from immunized xenomice
02/24/2012CA2770276A1 Preventing and curing beneficial insect diseases via plant transcribed molecules
02/23/2012WO2012024662A2 Expression constructs comprising fungal promoters
02/23/2012WO2012024659A2 Antibody-based constructs directed against tyrosine kinase receptors
02/23/2012WO2012024535A2 Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd)
02/23/2012WO2012024478A2 Treatment of nicotinamide phosphoribosyltransferase (nampt) related diseases by inhibition of natural antisense transcript to nampt
02/23/2012WO2012024372A2 Novel bacillus thuringiensis gene with coleopteran activity
02/23/2012WO2012024351A2 Adenoviral assembly method
02/23/2012WO2012024350A2 Anti-cancer adenoviruses
02/23/2012WO2012024200A2 Novel bacillus thuringiensis gene with lepidopteran activity
02/23/2012WO2012024176A2 Novel bacillus thuringiensis gene with lepidopteran activity
02/23/2012WO2012023960A2 Transgenically mitigating the establishment and spread of transgenic algae in natural ecosystems by suppressing the activity of a carbon concentrating mechanism
02/23/2012WO2012023838A2 Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same
02/23/2012WO2012023811A2 Pharmaceutical composition for suppressing angiogenesis, and method for screening active material for suppressing angiogenesis
02/23/2012WO2012023675A1 Modified nucleotides and real-time polymerase reaction using same
02/23/2012WO2012023648A1 Diagnostic composition for non-small-cell lung cancer comprising a preparation for measuring the hoxa11 gene methylation level, and a diagnostic method for non-small-cell lung cancer using the same
02/23/2012WO2012023641A1 Peptide for controlling red algal blooms having an anti-algal activity against red-bloom-inducing organisms, a use therefor and a production method therefor
02/23/2012WO2012023622A1 Reagent for tumor testing and pharmaceutical composition for tumor prevention
02/23/2012WO2012023588A1 Diagnostic marker for malignant melanoma, pharmaceutical composition containing substance suppressing function of histatin-1 protein, and immunosuppressive agent
02/23/2012WO2012023583A1 Flavin enzyme having flavonol 8-hydroxylase activity and use thereof
02/23/2012WO2012023580A1 Method for producing low immunogenic streptavidin having antibody bonded thereto
02/23/2012WO2012023569A1 Solution for extraction of rna
02/23/2012WO2012023486A1 Antifreeze protein
02/23/2012WO2012023345A1 Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom
02/23/2012WO2012023290A1 Rasef as tumor marker and therapeutic target for cancer
02/23/2012WO2012023288A1 Fam161a as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023287A1 Suv420h1 and suv420h2 as target genes for cancer therapy and diagnosis
02/23/2012WO2012023286A1 Lrrc42 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023285A1 Ehmt2 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023284A1 Lhx4 as a target gene for cancer therapy and diagnosis
1 ... 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 ... 4023